Torres Crigna Adriana, Fricke Fabia, Nitschke Katja, Worst Thomas, Erb Ulrike, Karremann Michael, Buschmann Dominik, Elvers-Hornung Susanne, Tucher Christine, Schiller Martin, Hausser Ingrid, Gebert Johannes, Bieback Karen
Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Donor Service Baden-Württemberg-Hessen, Mannheim, Germany.
Department of Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Transfus Med Hemother. 2021 Feb;48(1):48-59. doi: 10.1159/000508712. Epub 2020 Jul 8.
BACKGROUND/AIMS: Extracellular vesicles (EVs), including microvesicles and exosomes, deliver bioactive cargo mediating intercellular communication in physiological and pathological conditions. EVs are increasingly investigated as therapeutic agents and targets, but also as disease biomarkers. However, a definite consensus regarding EV isolation methods is lacking, which makes it intricate to standardize research practices and eventually reach a desirable level of data comparability. In our study, we performed an inter-laboratory comparison of EV isolation based on a differential ultracentrifugation protocol carried out in 4 laboratories in 2 independent rounds of isolation.
Conditioned medium of colorectal cancer cells was prepared and pooled by 1 person and distributed to each of the participating laboratories for isolation according to a pre-defined protocol. After EV isolation in each laboratory, quantification and characterization of isolated EVs was collectively done by 1 person having the highest expertise in the respective test method: Western blot, flow cytometry (fluorescence-activated cell sorting [FACS], nanoparticle tracking analysis (NTA), and transmission electron microscopy (TEM).
EVs were visualized with TEM, presenting similar cup-shaped and spherical morphology and sizes ranging from 30 to 150 nm. NTA results showed similar size ranges of particles in both isolation rounds. EV preparations showed high purity by the expression of EV marker proteins CD9, CD63, CD81, Alix, and TSG101, and the lack of calnexin. FACS analysis of EVs revealed intense staining for CD63 and CD81 but lower levels for CD9 and TSG101. Preparations from 1 laboratory presented significantly lower particle numbers ( < 0.0001), most probably related to increased processing time. However, even when standardizing processing time, particle yields still differed significantly between groups, indicating inter-laboratory differences in the efficiency of EV isolation. Importantly, no relation was observed between centrifugation speed/k-factor and EV yield.
Our findings demonstrate that quantitative differences in EV yield might be due to equipment- and operator-dependent technical variability in ultracentrifugation-based EV isolation. Furthermore, our study emphasizes the need to standardize technical parameters such as the exact run speed and k-factor in order to transfer protocols between different laboratories. This hints at substantial inter-laboratory biases that should be assessed in multi-centric studies.
背景/目的:细胞外囊泡(EVs),包括微囊泡和外泌体,在生理和病理条件下传递生物活性物质,介导细胞间通讯。EVs作为治疗剂和靶点,以及疾病生物标志物,受到越来越多的研究。然而,关于EV分离方法缺乏明确的共识,这使得标准化研究实践并最终达到理想的数据可比性水平变得复杂。在我们的研究中,我们基于在4个实验室进行的两轮独立分离中采用的差速超速离心方案,进行了EV分离的实验室间比较。
由1人制备并汇集结肠癌细胞的条件培养基,按照预先定义的方案分发给每个参与实验室进行分离。在每个实验室分离出EV后,由在各自测试方法(蛋白质印迹法、流式细胞术(荧光激活细胞分选法[FACS])、纳米颗粒跟踪分析(NTA)和透射电子显微镜(TEM))方面具有最高专业知识的1人共同完成对分离出的EV的定量和表征。
通过TEM观察到EV,呈现出类似杯状和球形的形态,大小范围为30至150nm。NTA结果显示在两轮分离中颗粒的大小范围相似。通过EV标志物蛋白CD9、CD63、CD81、Alix和TSG101的表达以及钙连接蛋白的缺乏,表明EV制剂具有高纯度。对EV的FACS分析显示CD63和CD81染色强烈,但CD9和TSG101水平较低。来自1个实验室的制剂呈现出显著较低的颗粒数(<0.0001),这很可能与处理时间增加有关。然而,即使标准化处理时间,不同组之间的颗粒产量仍然存在显著差异,表明实验室间在EV分离效率上存在差异。重要的是,未观察到离心速度/k因子与EV产量之间的关系。
我们的研究结果表明,EV产量的定量差异可能是由于基于超速离心的EV分离中设备和操作人员相关的技术变异性。此外,我们的研究强调需要标准化技术参数,如精确的运行速度和k因子,以便在不同实验室之间转移方案。这暗示了在多中心研究中应评估的显著的实验室间偏差。